News & Press Center
Get the latest news and press announcements from LexisNexis®️ Intellectual Property Solutions.
LexisNexis® Intellectual Property Solutions Launches Japanese Version of IP Analytics Platform
LexisNexis expands its Intellectual Property Solutions suite with the acquisition of IPlytics
LexisNexis® Releases PTAB Argument Finder, New Tool to Help Patent Attorneys Surface Winning Arguments in USPTO Appeals
LexisNexis®️ Introduces LexisNexis PatentAdvisor®️ Extension, Free Web Tool to Display Patent Examiner Stats on USPTO Websites
IP Analytics & Intelligence
LexisNexis® Acknowledges the World’s Outperforming Companies With its “Innovation Momentum 2022: The Global Top 100” Report
LexisNexis® Further Champions the Needs of Patent Professionals With a New High-Value Dataset Supporting More Accurate and Relevant Prosecution Guidance
LexisNexis Launches New Sustainable Innovation Measurement Framework Enabling Organizations Globally to Objectively Track and Report on Innovation’s Contribution to the United Nations Sustainable Development Goals
Study Finds 55% of Intellectual Property Leaders Consider Navigating Budget Restrictions Their Top Priority for the Year
In the News
Check out articles mentioning LexisNexis Intellectual Property Solutions
Elsevier Press Release
Reaxys to enhance chemistry patents with patent provenance for greater competitive intelligence insights
‘Next-generation semiconductor’ technology that ‘Sony’ in Japan pays attention to
SDGs goal 11, NEC expects Japan’s top Toyota Woven City in 22nd place
Patent Analysis Can Help Companies Avoid Being Blindsided by Competitive Threats
Patent Trends Foretell Chipmakers’ Fortunes
Which company will supply the autonomous vehicle ‘LiDAR’ to ‘Apple’ in the US?
These 39 companies are doing corporate social responsibility right
Digitisation climbs up legal agenda
Elsevier report highlights exponential growth of Chinese patents in carbon-free energy technologies
Green, Yellow, Or Red: What Color Is Your Patent Examiner and Why Should You Care?
Johnson & Johnson, Gilead and Roche are the world’s antiviral patent leaders
Moderna, Nike and TSMC among pandemic-era outperformers in patent portfolio strength
Why 5G Patent ‘Value’ Is More Important Than The ‘Number’ Of Patents
Elsevier and LexisNexis collaborate to increase access to patent information in pharma and chemical R&D workflows
The seeds of innovation are in-house
Check out more intellectual property content and resources.